674 related articles for article (PubMed ID: 30861110)
21. Capturing Adult Patient Preferences Toward Benefits and Risks of Second-Line Antihyperglycemic Medications Used in Type 2 Diabetes: A Discrete Choice Experiment.
Donnan JR; Johnston K; Chibrikov E; Marra CA; Aubrey-Bassler K; Najafzadeh M; Nguyen H; Gamble JM
Can J Diabetes; 2020 Feb; 44(1):6-13. PubMed ID: 31311729
[TBL] [Abstract][Full Text] [Related]
22. Hemodialysis patients' preferences for the management of anemia.
Hauber B; Caloyeras J; Posner J; Brommage D; Tzivelekis S; Pollock A
BMC Nephrol; 2017 Jul; 18(1):253. PubMed ID: 28750609
[TBL] [Abstract][Full Text] [Related]
23. Patient Preferences for Treating "OFF" Episodes in Parkinson's Disease: A Discrete Choice Experiment.
Thach A; Sutphin J; Coulter J; Leach C; Pappert E; Mansfield C
Patient Prefer Adherence; 2021; 15():1187-1196. PubMed ID: 34103902
[TBL] [Abstract][Full Text] [Related]
24. Treatment preference among patients with spinal muscular atrophy (SMA): a discrete choice experiment.
Monnette A; Chen E; Hong D; Bazzano A; Dixon S; Arnold WD; Shi L
Orphanet J Rare Dis; 2021 Jan; 16(1):36. PubMed ID: 33472673
[TBL] [Abstract][Full Text] [Related]
25. Patient preferences for osteoarthritis pain and chronic low back pain treatments in the United States: a discrete-choice experiment.
Turk D; Boeri M; Abraham L; Atkinson J; Bushmakin AG; Cappelleri JC; Hauber B; Klein K; Russo L; Viktrup L; Walsh D
Osteoarthritis Cartilage; 2020 Sep; 28(9):1202-1213. PubMed ID: 32652238
[TBL] [Abstract][Full Text] [Related]
26. Patients' Preferences Related to Benefits, Risks, and Formulations of Schizophrenia Treatment.
Levitan B; Markowitz M; Mohamed AF; Johnson FR; Alphs L; Citrome L; Bridges JF
Psychiatr Serv; 2015 Jul; 66(7):719-26. PubMed ID: 25772762
[TBL] [Abstract][Full Text] [Related]
27. Preferences for Adjuvant Immunotherapy in Adults with Resected Stage III Melanoma-A Discrete Choice Experiment.
Livingstone A; Howard K; Menzies AM; Long GV; Stockler MR; Morton RL
Patient; 2023 Sep; 16(5):497-513. PubMed ID: 37351797
[TBL] [Abstract][Full Text] [Related]
28. My Migraine Voice survey: a global study of disease burden among individuals with migraine for whom preventive treatments have failed.
Martelletti P; Schwedt TJ; Lanteri-Minet M; Quintana R; Carboni V; Diener HC; Ruiz de la Torre E; Craven A; Rasmussen AV; Evans S; Laflamme AK; Fink R; Walsh D; Dumas P; Vo P
J Headache Pain; 2018 Nov; 19(1):115. PubMed ID: 30482181
[TBL] [Abstract][Full Text] [Related]
29. Physician and patient preferences for dosing options in migraine prevention.
Cowan R; Cohen JM; Rosenman E; Iyer R
J Headache Pain; 2019 May; 20(1):50. PubMed ID: 31072307
[TBL] [Abstract][Full Text] [Related]
30. Conducting a Discrete-Choice Experiment Study Following Recommendations for Good Research Practices: An Application for Eliciting Patient Preferences for Diabetes Treatments.
Janssen EM; Hauber AB; Bridges JFP
Value Health; 2018 Jan; 21(1):59-68. PubMed ID: 29304942
[TBL] [Abstract][Full Text] [Related]
31. A discrete-choice experiment to quantify patient preferences for frequency of glucagon-like peptide-1 receptor agonist injections in the treatment of type 2 diabetes.
Hauber AB; Nguyen H; Posner J; Kalsekar I; Ruggles J
Curr Med Res Opin; 2016; 32(2):251-62. PubMed ID: 26549576
[TBL] [Abstract][Full Text] [Related]
32. What Features of Fertility Treatment do Patients Value? Price Elasticity and Willingness-to-Pay Values from a Discrete Choice Experiment.
Keller E; Botha W; Chambers GM
Appl Health Econ Health Policy; 2023 Jan; 21(1):91-107. PubMed ID: 36171511
[TBL] [Abstract][Full Text] [Related]
33. Patient and caregiver benefit-risk preferences for nonmetastatic castration-resistant prostate cancer treatment.
Srinivas S; Mohamed AF; Appukkuttan S; Botteman M; Ng X; Joshi N; Tsai JH; Fang J; Waldeck AR; Simmons SJ
Cancer Med; 2020 Sep; 9(18):6586-6596. PubMed ID: 32725755
[TBL] [Abstract][Full Text] [Related]
34. Patient preferences and predicted relative uptake for targeted therapies in metastatic colorectal cancer: a discrete choice experiment.
Wong XY; Lim AQJ; Shen Q; Chia JWK; Chew MH; Tan WS; Wee HL
Curr Med Res Opin; 2020 Oct; 36(10):1677-1686. PubMed ID: 32609014
[TBL] [Abstract][Full Text] [Related]
35. Patients' preferences for headache acute and preventive treatment.
Mitsikostas DD; Belesioti I; Arvaniti C; Mitropoulou E; Deligianni C; Kasioti E; Constantinidis T; Dermitzakis M; Vikelis M;
J Headache Pain; 2017 Oct; 18(1):102. PubMed ID: 28986900
[TBL] [Abstract][Full Text] [Related]
36. Patient preferences for first-line oral treatment for mild-to-moderate ulcerative colitis: a discrete-choice experiment.
Hodgkins P; Swinburn P; Solomon D; Yen L; Dewilde S; Lloyd A
Patient; 2012; 5(1):33-44. PubMed ID: 22077619
[TBL] [Abstract][Full Text] [Related]
37. Patient Preferences for Attributes of Type 2 Diabetes Mellitus Medications in Germany and Spain: An Online Discrete-Choice Experiment Survey.
Mansfield C; Sikirica MV; Pugh A; Poulos CM; Unmuessig V; Morano R; Martin AA
Diabetes Ther; 2017 Dec; 8(6):1365-1378. PubMed ID: 29101681
[TBL] [Abstract][Full Text] [Related]
38. The Patient Voice: Exploring Treatment Preferences in Participants with Mild Cognitive Concerns to Inform Regulatory Decision Making.
Mansfield C; Bullok K; Fuhs JV; Tockhorn-Heidenreich A; Andrews JS; DiBenedetti D; Matthews BR; Darling JC; Sutphin J; Hauber B
Patient; 2022 Sep; 15(5):551-564. PubMed ID: 35435572
[TBL] [Abstract][Full Text] [Related]
39. Preferences for improvements in attributes associated with basal insulin: a time trade-off and willingness-to-pay survey of a diabetic and non-diabetic population in Sweden.
Olofsson S; Norrlid H; Persson U
J Med Econ; 2016 Oct; 19(10):945-58. PubMed ID: 27149402
[TBL] [Abstract][Full Text] [Related]
40. Patient preferences for a polypill for the prevention of cardiovascular diseases.
Laba TL; Howard K; Rose J; Peiris D; Redfern J; Usherwood T; Cass A; Patel A; Jan S
Ann Pharmacother; 2015 May; 49(5):528-39. PubMed ID: 25680761
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
